Left atrial appendage occlusion: 2016 in review.

about

Left atrial appendage occlusion: 2016 in review.

Item

http://www.wikidata.org/entity/Q38629267

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Left atrial appendage occlusion: 2016 in review.

@en

type

Item

label

Left atrial appendage occlusion: 2016 in review.

@en

prefLabel

Left atrial appendage occlusion: 2016 in review.

@en

P1476

Left atrial appendage occlusion: 2016 in review

@en

P2093

Bonnie Young

http://www.w3.org/2001/XMLSchema#string

Kishore Harjai

http://www.w3.org/2001/XMLSchema#string

Pugazhendhi Vijayaraman

http://www.w3.org/2001/XMLSchema#string

Vernon Mascarenhas

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience.

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.

Left Atrial Appendage Closure Under Intracardiac Echocardiographic Guidance: Feasibility and Comparison With Transesophageal Echocardiography.

Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).

Rationale of cerebral protection devices in left atrial appendage occlusion.

Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.

P304

448-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIC.12410

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel de J Ramos Ramirez

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28799239

http://www.w3.org/2001/XMLSchema#string

Left atrial appendage occlusion: 2016 in review.

about

Left atrial appendage occlusion: 2016 in review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698